Beacon Hormone & Wellness

10/14/2026

Two people can have the exact same LDL and very different risk of a heart attack.

One of the most controversial topics in medicine is cholesterol and statins, which effectively lower LDL (“bad” cholesterol). Organizations like the American College of Cardiology and American Heart Association recommend lowering LDL to less than 70 mg/dL for primary prevention of ASCVD (atherosclerotic cardiovascular disease) for people whose 10-year risk is 10% or higher. This might make sense for some people.

The “lower LDL is always better” argument has become more of a slogan than a conclusion — repeated so often that questioning it gets treated like heresy instead of normal scientific inquiry.

Dr. Nick Norwitz, a physician-researcher (Oxford PhD, Harvard MD), wrote a piece worth reading on this: “When Cholesterol Science Becomes Religion”. He uses a real case — a 55-year-old woman whose LDL is already 75 mg/dL — to ask whether pushing an already-low number even lower reliably helps her, or whether we’re reciting a rule instead of looking at her actual evidence. I agree with where he lands.

Here is a link to his article on substack:
https://staycuriousmetabolism.substack.com/p/when-moderation-looks-radical?r=40ekz2&utm_campaign=post&utm_medium=web&triedRedirect=true&has_completed_unsubscribed_unlock=true

My take: LDL matters, but it was never the whole story. Dr. Benjamin Bikman makes a similar case in Why We Get Sick — he argues insulin resistance may be the single most relevant variable in heart disease, more than any one lipid number. One practical example from his work: your triglyceride-to-HDL ratio (just divide the two numbers off your last lipid panel) is a strong proxy for LDL particle size. A low ratio (under ~2.0) skews toward larger, more buoyant LDL particles — generally less atherogenic. A high ratio means more small, dense particles, which pe*****te the artery wall more easily. Two people with identical LDL can have very different real risk based on this ratio alone — and you can calculate it from labs you probably already have.

This is why cardiovascular risk assessment at Beacon goes beyond a standard lipid panel — ApoB, Lp(a), insulin resistance markers, hs-crp, and imaging like a CAC score when the picture is unclear. Not a slogan. Your actual risk.

When “lower LDL is always better” becomes dogma, even asking questions can look radical. Here’s what one cholesterol controversy reveals about evidence, medicine, and scientific humility.

09/23/2026

Hot flashes are probably the symptom most people associate with menopause.

But menopause can affect much more than temperature regulation.

Changes in sleep, mood, energy, cognition, body composition, and overall well-being can also be part of the conversation—and they deserve attention too.

I wrote a short article about why the menopause conversation needs to go beyond hot flashes.

👇 Read the full article:
https://www.healthoverwealth.us/articles/why-does-the-menopause-conversation-always-stop-at-hot-flashes

09/18/2026

"Is this just getting older, or is something actually off?"

It's one of the most common questions I hear from men in their 40s and 50s — usually after months (sometimes years) of just pushing through lower energy, slower recovery, and motivation that doesn't come as easily as it used to.

Here's what's worth knowing: testosterone does decline naturally with age — about 1-2% per year after 30. Most men in their 40s and 50s are still in the "normal" range. But normal on paper and normal for how you actually feel are two different things. I've seen men with numbers inside the reference range who feel awful, and men with lower numbers who feel completely fine. The lab value alone doesn't tell the whole story.

Part of the problem: most standard testing only looks at total testosterone. It often misses free testosterone, SHBG, and estradiol — the fuller picture that actually explains symptoms.

If you've been wondering whether what you're feeling deserves a real look instead of a shrug, I wrote more about what to test and what the numbers actually mean here:

09/16/2026

As the days get shorter here in Washington, you may notice changes in your energy, sleep, motivation, or mood.

But how do you know when it’s simply the change in daylight and when something else—like hormones, sleep, or other aspects of your health—may be contributing?

I wrote a short article exploring some of the reasons we can feel noticeably different once the sun goes down earlier.

👇 Read the full article here:

https://www.healthoverwealth.us/articles/why-do-i-feel-so-much-worse-once-it-gets-dark-in-washington

09/15/2026

Weather changes moods, but so do hormones. How can you tell the difference?

Check out the article below:

08/24/2026

For 20 years, hormone therapy in menopause has been shadowed by a single study.

The 2002 Women's Health Initiative reported increased breast cancer and cardiovascular risk with combined hormone therapy. Prescriptions dropped by over 70% overnight. Millions of women declined treatment that could have helped them.

But that study was primarily conducted in women in their 60s and 70s, most starting HRT more than 10 years after menopause. The findings were widely — and inappropriately — applied to symptomatic women in their 50s.

Two decades of reanalysis have substantially changed the picture. Here's what the evidence actually shows.

Breast cancer:

Estrogen-only therapy (in women without a uterus) has been associated with a 23% reduction in breast cancer incidence and a 40% reduction in breast cancer mortality on 20-year follow-up.

Combined estrogen + progestogen therapy does carry a small increased risk — approximately 8 additional cases per 10,000 women per year, or 0.08% absolute increase. That's smaller than the risk from moderate alcohol use, obesity, or a sedentary lifestyle.

Cardiovascular:

For women who start hormone therapy under age 60 or within 10 years of menopause, HRT is associated with approximately 35% lower coronary heart disease and 21% lower all-cause mortality. The heart risk in the original WHI was concentrated in women who started more than 10 years after menopause — a very different population than the one that gets treated today.

Bone health:

HRT reduces hip fracture risk by approximately 33%. It remains one of the most effective osteoporosis prevention strategies available.

The 2024-2025 FDA update:

Last year, the FDA removed the boxed warnings on menopausal hormone therapy that had been in place since 2003. The updated labeling reflects modern understanding: risk depends on age at initiation, formulation, and route of administration. Transdermal estrogen carries lower blood clot and stroke risk than oral. Micronized progesterone appears safer than synthetic progestins.

Who benefits most:

Symptomatic women under 60 or within 10 years of menopause onset, without specific contraindications (active breast or hormone-sensitive cancer, unexplained vaginal bleeding, history of blood clots, active liver disease). This is the majority of women in perimenopause and early menopause.

The bottom line:

The last 20 years of hormone therapy have been dominated by fear based on a study that was misinterpreted at the time and has been substantially revised since. For most healthy women in perimenopause or early menopause with bothersome symptoms, the benefits outweigh the risks — a conclusion now endorsed by the Menopause Society, the FDA, and virtually every current major medical organization.

If you were told years ago that HRT wasn't safe, the evidence has moved. It's worth reconsidering the conversation.

For a deeper look at hormone therapy in perimenopause and menopause, I've written more at:

https://www.beaconhormone.com/hrt-long-term-benefits-women.html

07/08/2026

"I don't have time to exercise."

I hear this often — usually from patients working on insulin resistance, prediabetes, or PCOS. And I understand it. The standard advice (walk 30 minutes a day, hit the gym 4 times a week) doesn't fit everyone's life.

Here's what most people aren't told: you don't need structured exercise to move glucose out of your blood.

The reason is a mechanism called GLUT4 translocation. When your muscles contract — any contraction, not just walking — transporters rise to the cell surface and pull glucose in. No insulin required. This is why exercise works even in people whose insulin isn't working well.

So the goal isn't 30 minutes of walking specifically. The goal is: contract your muscles, often.

Options that work when time is tight:

• Bodyweight squats — 30 seconds every hour. Research shows this alone measurably improves post-meal glucose.
• Wall sits during phone calls
• Calf raises while brushing teeth or standing in line
• Tensing quads and glutes while sitting in meetings (nobody sees it, glucose still moves)
• Taking stairs instead of the elevator
• Standing up every 30 minutes and doing 10 air squats

And when you can build in longer sessions:

• Resistance training 2-3x weekly is the highest-leverage intervention. It builds muscle mass — the actual glucose disposal capacity of your body. Effects on insulin sensitivity last 24-72 hours per session. Even 20-minute sessions work.

The reframe:

Muscle is your body's glucose engine. Building more of it expands your capacity. Using it more often — in whatever form fits your day — keeps glucose moving out of your blood.

The post-meal walk is one form of this. It's not the only form. And it's not required.

If structured exercise isn't practical, small contractions still work. The system isn't picky about how you contract. It's picky about whether you contract at all.

07/06/2026

A conversation that should happen before any man starts testosterone therapy — and often doesn't:

"Are you planning to have children?"

Here's why it matters.

When a man takes external testosterone, his brain notices. It stops signaling the te**es to make their own. Endogenous testosterone production shuts down. So does s***m production.

For most men on TRT, this means effective infertility within 3 to 6 months. Sometimes it recovers when treatment stops. Sometimes it doesn't. And when it does recover, it often takes a year or longer.

This isn't a rare complication. It's the expected physiology. And it's not part of the initial conversation at most clinics prescribing testosterone.

What should be discussed instead:

If you want children now, clomiphene or enclomiphene can raise your own testosterone production rather than replacing it. Many men see significant symptom improvement without touching fertility.

If you want children later, TRT combined with HCG can maintain testicular function and s***m production while you're on treatment.

If you're done with kids, standard TRT is often the right choice — with appropriate monitoring and attention to what testosterone alone doesn't fix.

S***m banking before starting treatment is also an option. Every man of reproductive age deserves to hear about it before making a decision.

The right approach depends on your fertility goals. That conversation belongs at the beginning — not after you've been on testosterone for a year and realize no one asked.

If you're considering testosterone therapy, ask your clinician about fertility before starting. If they don't have an answer, find one who does.

https://www.beaconhormone.com/

06/17/2026

I was recently asked by someone "Why is exercise such a big deal?" (in regard to metabolic and hormone health)

Most people assume the answer is calories. It's not.

Here's what changed how I think about exercise as a clinician: muscle is one of the largest endocrine (hormone-producing) organs in the body.

When muscles contract, they release dozens of signaling molecules called myokines. These act like hormones — traveling through the bloodstream and influencing the brain, immune system, fat tissue, bones, and pancreas.

A few examples:

IL-6, released during muscle contraction, is anti-inflammatory — lowering the chronic low-grade inflammation behind nearly every age-related disease.

BDNF (brain-derived neurotrophic factor) crosses into the brain and promotes neuron growth. Exercise is the most potent way to raise it. Strongly linked to better cognition, mood, and Alzheimer's protection.

Irisin signals fat tissue to become more metabolically active, burning more energy at rest.

Decorin and others appear to suppress tumor growth signals — part of the link between exercise and lower cancer risk.

This is why I tell patients: exercise is not just movement. It's hormonal therapy.

A few practical implications:

• Even 20 minutes triggers myokine release
• The effects persist long after the session ends
• Sedentary time is its own problem — no contraction, no signals
• Both resistance training and cardio matter (different myokine profiles)
• For perimenopausal and menopausal women especially, this matters even more — muscle loss accelerates in the transition

If you're working on insulin resistance, hormone balance, weight, mood, sleep, or cognition — the most powerful intervention may not require a prescription pad.

beaconhormone.com

06/05/2026

Perimenopause is often one of the more overlooked stages in women's health. Here is a blog article that helps explain this stage of life:

Perimenopause often begins years before your last period, and the symptoms are routinely dismissed as stress or aging. Here's what's really happening and what evidence-based care looks like.